Display options
Cite
Geißler C, Krause C, Neumann AM, et al. Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice. J Nutr Biochem. 2021;100:108907doi: 10.1016/j.jnutbio.2021.108907.
Geißler, C., Krause, C., Neumann, A. M., Britsemmer, J. H., Taege, N., Grohs, M., Kaehler, M., Cascorbi, I., Lewis, A. G., Seeley, R. J., Oster, H., & Kirchner, H. (2022). Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice. The Journal of nutritional biochemistry, 100108907. https://doi.org/10.1016/j.jnutbio.2021.108907
Geißler, Cathleen, et al. "Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice." The Journal of nutritional biochemistry vol. 100 (2022): 108907. doi: https://doi.org/10.1016/j.jnutbio.2021.108907
Geißler C, Krause C, Neumann AM, Britsemmer JH, Taege N, Grohs M, Kaehler M, Cascorbi I, Lewis AG, Seeley RJ, Oster H, Kirchner H. Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice. J Nutr Biochem. 2022 Feb;100:108907. doi: 10.1016/j.jnutbio.2021.108907. Epub 2021 Nov 18. PMID: 34801693.
Copy Download .nbib Format: NLM
Share it on

J Nutr Biochem. 2022 Feb;100:108907. doi: 10.1016/j.jnutbio.2021.108907. Epub 2021 Nov 18.

Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice.

The Journal of nutritional biochemistry

Cathleen Geißler, Christin Krause, Anne-Marie Neumann, Jan H Britsemmer, Natalie Taege, Martina Grohs, Meike Kaehler, Ingolf Cascorbi, Alfor G Lewis, Randy J Seeley, Henrik Oster, Henriette Kirchner

Affiliations

  1. Institute for Endocrinology and Diabetes, University of Lübeck, Germany; Institute for Human Genetics, Section Epigenetics & Metabolism, University of Lübeck, Germany; Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Germany.
  2. Institute for Human Genetics, Section Epigenetics & Metabolism, University of Lübeck, Germany; Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Germany; German Center for Diabetes Research (DZD).
  3. Institute of Neurobiology, University of Lübeck, Germany; Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Germany.
  4. Institute for Human Genetics, Section Epigenetics & Metabolism, University of Lübeck, Germany; Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Germany.
  5. Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Campus Kiel, Germany.
  6. Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.
  7. Institute for Human Genetics, Section Epigenetics & Metabolism, University of Lübeck, Germany; Center of Brain, Behavior and Metabolism (CBBM), University of Lübeck, Germany; German Center for Diabetes Research (DZD). Electronic address: [email protected].

PMID: 34801693 DOI: 10.1016/j.jnutbio.2021.108907

Abstract

DNA methylation is dynamically regulated in metabolic diseases, but it remains unclear whether the changes are causal or consequential. Therefore, we used a longitudinal approach to refine the onset of metabolic and DNA methylation changes at high temporal resolution. Male C57BL/6N mice were fed with 60 % high-fat diet (HFD) for up to 12 weeks and metabolically characterized weekly. Liver was collected after 1, 2, 4, 5, 6, 7, 8, and 12 weeks and hepatic DNA methylation and gene expression were analyzed. A subset of obese mice underwent vertical sleeve gastrectomy (VSG) or metformin treatment and livers were studied. Distinct hepatic gene expression patterns developed upon feeding HFD, with genes from the fatty acid metabolism pathway being predominantly altered. When comparing metabolic data with gene expression and DNA methylation, in particular Fgf21 DNA methylation decreased before the onset of increased Fgf21 expression and metabolic changes. Neither weight loss induced by VSG nor improved glucose tolerance by metformin treatment could revert hepatic Fgf21 DNA methylation or expression. Our data emphasize the dynamic induction of DNA methylation upon metabolic stimuli. Reduced Fgf21 DNA methylation established before massive overexpression of Fgf21, which is likely an adaptive effort of the liver to maintain glucose homeostasis despite the developing insulin resistance and steatosis. Fgf21 DNA methylation resisted reversion by intervention strategies, illustrating the long-term effects of unhealthy lifestyle. Our data provide a temporal roadmap to the development of hepatic insulin resistance, comprehensively linking DNA methylation with gene expression and metabolic data.

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Keywords: DNA methylation; FGF21; liver; type 2 diabetes

Publication Types